Data Sharing and Data Privacy - what every statistician needs to know
Data sharing, data transparency and data privacy are areas that continue to evolve. For example, EMA Policy 70 is now effective with proactive publication of submitted clinical overviews and study reports. It is becoming more common for clinical trial data to be used to support scientific questions beyond the objectives of the original study.
The intent of this webinar is to provide an outline to pharmaceutical statisticians of key issues and concepts everyone dealing with and sharing patient level data should be aware of.
Presentation #1 Sharing clinical trial data externally – key data privacy concepts every statistician should know (Janice Branson and Nicola Orlandi (Novartis)) Click here to view the slides
Presentation #2 Data Sources to help inform drug development – what you give is also what you get (Sally Hollis (Phastar) and Rebecca Sudlow (Roche)) Click here to view the slides
Data Sharing and Data Privacy - what every statistician needs to know
Data sharing, data transparency and data privacy are areas that continue to evolve. For example, EMA Policy 70 is now effective with proactive publication of submitted clinical overviews and study reports. It is becoming more common for clinical trial data to be used to support scientific questions beyond the objectives of the original study.
The intent of this webinar is to provide an outline to pharmaceutical statisticians of key issues and concepts everyone dealing with and sharing patient level data should be aware of.
Presentation #1 Sharing clinical trial data externally – key data privacy concepts every statistician should know (Janice Branson and Nicola Orlandi (Novartis)) Click here to view the slides
Presentation #2 Data Sources to help inform drug development – what you give is also what you get (Sally Hollis (Phastar) and Rebecca Sudlow (Roche)) Click here to view the slides
Data Sharing and Data Privacy - what every statistician needs to know
Data sharing, data transparency and data privacy are areas that continue to evolve. For example, EMA Policy 70 is now effective with proactive publication of submitted clinical overviews and study reports. It is becoming more common for clinical trial data to be used to support scientific questions beyond the objectives of the original study.
The intent of this webinar is to provide an outline to pharmaceutical statisticians of key issues and concepts everyone dealing with and sharing patient level data should be aware of.
Presentation #1 Sharing clinical trial data externally – key data privacy concepts every statistician should know (Janice Branson and Nicola Orlandi (Novartis)) Click here to view the slides
Presentation #2 Data Sources to help inform drug development – what you give is also what you get (Sally Hollis (Phastar) and Rebecca Sudlow (Roche)) Click here to view the slides
Data Sharing and Data Privacy - what every statistician needs to know
Data sharing, data transparency and data privacy are areas that continue to evolve. For example, EMA Policy 70 is now effective with proactive publication of submitted clinical overviews and study reports. It is becoming more common for clinical trial data to be used to support scientific questions beyond the objectives of the original study.
The intent of this webinar is to provide an outline to pharmaceutical statisticians of key issues and concepts everyone dealing with and sharing patient level data should be aware of.
Presentation #1 Sharing clinical trial data externally – key data privacy concepts every statistician should know (Janice Branson and Nicola Orlandi (Novartis)) Click here to view the slides
Presentation #2 Data Sources to help inform drug development – what you give is also what you get (Sally Hollis (Phastar) and Rebecca Sudlow (Roche)) Click here to view the slides
Data Sharing and Data Privacy - what every statistician needs to know
Data sharing, data transparency and data privacy are areas that continue to evolve. For example, EMA Policy 70 is now effective with proactive publication of submitted clinical overviews and study reports. It is becoming more common for clinical trial data to be used to support scientific questions beyond the objectives of the original study.
The intent of this webinar is to provide an outline to pharmaceutical statisticians of key issues and concepts everyone dealing with and sharing patient level data should be aware of.
Presentation #1 Sharing clinical trial data externally – key data privacy concepts every statistician should know (Janice Branson and Nicola Orlandi (Novartis)) Click here to view the slides
Presentation #2 Data Sources to help inform drug development – what you give is also what you get (Sally Hollis (Phastar) and Rebecca Sudlow (Roche)) Click here to view the slides
Data Sharing and Data Privacy - what every statistician needs to know
Data sharing, data transparency and data privacy are areas that continue to evolve. For example, EMA Policy 70 is now effective with proactive publication of submitted clinical overviews and study reports. It is becoming more common for clinical trial data to be used to support scientific questions beyond the objectives of the original study.
The intent of this webinar is to provide an outline to pharmaceutical statisticians of key issues and concepts everyone dealing with and sharing patient level data should be aware of.
Presentation #1 Sharing clinical trial data externally – key data privacy concepts every statistician should know (Janice Branson and Nicola Orlandi (Novartis)) Click here to view the slides
Presentation #2 Data Sources to help inform drug development – what you give is also what you get (Sally Hollis (Phastar) and Rebecca Sudlow (Roche)) Click here to view the slides
PSI Introduction to Industry Training (ITIT) Course - 2025/2026
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This is an interactive online training workshop providing an in-depth review of the estimand framework as laid out by ICH E9(R1) addendum with inputs from estimand experts, case studies, quizzes and opportunity for discussions. You will develop an estimand in a therapeutic area of interest to your company. In an online break-out room, you will join a series of team discussions to implement the estimand framework in a case study, aligning estimands, design, conduct, analysis, (assumptions + sensitivity analyses) to the clinical objective and therapeutic setting.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
Who is this event intended for? Statisticians with an interest understanding dose-finding in oncology.
What is the benefit of attending? Learn about the state of oncology dose finding, particularly in light of current FDA guidance.
PSI Book Club Webinar: Atomic Habits - The Science of Getting Your Act Together
The book club’s usual focus is to read and discuss professional development books. In this short format event you can more easily develop you career without the commitment of reading the whole book - simply listen to the 1-hour long podcast before joining the interactive session on 21 May.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
The BioMarin internship programme will enable students to gain valuable experience and knowledge of the processes and systems within BioMarin, whilst gaining an insight into the pharmaceutical/biotech industry.